India Diabetes Care Drugs Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2026

The Indian diabetes care drugs market is anticipated to grow at a significant CAGR during the forecast period (2020-2026). The key factor that drives the growth of the market is the rising prevalence of diabetes in the country. India has the second-largest number of adults with diabetes globally. As per the IDF, there were 77 million adults (20-79 years) suffering from diabetes in 2019.

To Request a Sample of our Report on India Diabetes Care Drugs Market: https://www.omrglobal.com/request-sample/india-diabetes-care-drugs-market

Moreover, the rising aging population is also among one of the key drivers of the Indian diabetes care drugs industry. As per the World Bank, there is more than 83 million elderly population (65 and above) that is over 6.1% of the total population. As older peoples are more prone to diseases such as diabetes, joint pain among others which creates scope for the market.

As per the projections by the IDF, the diabetes prevalence is likely to reach more than 101.0 million in 2030 and further reach 134.2 million in 2045. Furthermore, the increased spending on healthcare and particularly diabetes is also likely to support the growth of the market over the forecast period. As per the World Economic Forum (WEF), the GDP of the country in 2018 was $2.9 trillion. According to the National Health Portal of India, India spends only 1.02% of its GDP on public health. The presence of the key players also supports the growth of the market over the forecast period.

Market Coverage

· Market number available for – 2019-2026

· Base year- 2019

· Forecast period- 2020-2026

· Segment Covered- By Drug Class

· Region Covered- India

· Competitive Landscape- Eli Lilly & Co., Johnson & Johnson Services Inc., Merck & Co. Inc., Sanofi SA, Sun Pharmaceuticals Industries Ltd., and Takeda Pharmaceuticals Industries Ltd.

(Get 15% Discount on Buying this Report)

A full Report of India Diabetes Care Drugs Market is Available at: https://www.omrglobal.com/industry-reports/india-diabetes-care-drugs-market

India Diabetes Care Drugs Market – Segmentation

By Drug Class

· Insulins

· Non-Insulin Injectable Drugs

· Oral Anti-Diabetic Drugs

· Combination Drugs

Company Profiles

· AstraZeneca Plc

· Eli Lilly and Co.

· Johnson & Johnson Services Inc.

· Merck & Co. Inc.

· Mylan NV

· Novo Nordisk A/S

· Pfizer Inc.

· Sanofi SA

· Sun Pharmaceuticals Industries Ltd.

· Takeda Pharmaceuticals Industries Ltd.

· Teva Pharmaceuticals Industries Lt

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.